glp-faq
All FAQs
FAQlifestyle

Does semaglutide affect levothyroxine absorption?

Semaglutide slows gastric emptying and can impair levothyroxine absorption. Take levothyroxine on an empty stomach 30–60 min before anything else.

Updated May 26, 2026 · 4 min read

Yes — semaglutide can reduce levothyroxine absorption, and it's a clinically relevant interaction for the significant overlap between hypothyroid patients and GLP-1 users. The mechanism isn't a direct chemical interaction between the two drugs; it's semaglutide's effect on gastric emptying that causes the problem.

Why gastric emptying matters for levothyroxine

Levothyroxine (brand names Synthroid, Levoxyl, Tirosint, and others) is famously finicky about absorption. It's an oral tablet that must be absorbed primarily in the small intestine, and the absorption rate depends critically on several factors:

  • Fasting state — food, coffee, and other drugs in the stomach all reduce absorption
  • Transit time — how quickly the pill moves from stomach to small intestine
  • Gastric pH — acid is needed to dissolve the tablet properly

Semaglutide slows gastric emptying — intentionally, as part of its mechanism. This means food, liquids, and co-administered medications sit in the stomach longer. For levothyroxine, longer gastric transit = more time for absorption-reducing interactions, and potential exposure to less-than-ideal pH conditions as the stomach continues to process everything.

There's no published clinical trial that directly measured levothyroxine AUC before and after starting semaglutide in the same patients. What we have is: (1) the pharmacokinetic prediction from first principles, (2) case reports and clinician observations of patients requiring TSH rechecks after starting GLP-1s, and (3) the FDA's general guidance that semaglutide "may influence the absorption of concomitantly administered oral medications" — with levothyroxine being the classic oral medication most sensitive to absorption changes.

What this looks like in practice

If you're well-controlled on levothyroxine (TSH in range) and you start semaglutide, your TSH may rise over the next few months. This happens because less levothyroxine is being absorbed, leading to lower T4 levels, which prompts the pituitary to secrete more TSH. You may notice symptoms of undertreated hypothyroidism: fatigue (difficult to distinguish from GLP-1 side effects), cold intolerance, constipation, brain fog, weight plateau.

The practical risk: this interaction is easy to miss because hypothyroid symptoms overlap with early GLP-1 side effects, and many patients don't connect the dots until a routine TSH check shows the problem.

The spacing strategy

The key intervention is straightforward: take levothyroxine on a completely empty stomach, at least 30–60 minutes before anything else. This is standard guidance for levothyroxine regardless of other medications — but it becomes more important on semaglutide.

Practical protocol:

  1. Wake up — take levothyroxine with a small glass of water
  2. Wait 30–60 minutes — ideally 60 for Synthroid/generic; Tirosint gel caps may be somewhat more forgiving
  3. Then eat breakfast, take other medications (including GLP-1, if you were taking it in the morning), drink coffee

Note: semaglutide is a weekly injection, so levothyroxine spacing isn't about timing those two drugs on the same day. The concern is that semaglutide's persistent effect on gastric motility (which doesn't switch off between weekly doses) alters the stomach environment around the clock. Taking levothyroxine first thing in the morning on an empty stomach is the most reliable way to ensure it absorbs well regardless of what the rest of the day looks like.

When to recheck TSH

If you start semaglutide while on a stable levothyroxine dose, most endocrinologists recommend rechecking TSH 8–12 weeks after starting the GLP-1. This is quicker than the usual 6-month TSH check interval. If TSH has risen meaningfully, your levothyroxine dose may need to be adjusted upward — or the spacing strategy needs to be reviewed.

If your TSH was already borderline high before starting semaglutide, tighten the timeline — check at 6–8 weeks.

TSH levels also change with significant weight loss on their own (the set point shifts), so interpretation is slightly complex: a rising TSH on semaglutide could reflect the levothyroxine absorption issue, or it could reflect thyroid function changes secondary to weight loss. Your endocrinologist will likely track both.

What about other thyroid medications?

Liothyronine (T3, Cytomel): The same absorption principles apply. T3 has a shorter half-life than T4, so absorption variability matters more — a missed or reduced dose is noticed more quickly. Same spacing recommendation.

Tirosint (levothyroxine gel caps or liquid): The liquid and gel-cap formulations are designed to bypass some absorption variability — they don't require the same acid-dependent dissolution step as conventional tablets. Some patients switched to Tirosint before starting a GLP-1 specifically to reduce this interaction. The evidence that this fully eliminates the problem is limited, but it may help in patients who are struggling.

NP Thyroid / Armour Thyroid (desiccated thyroid): These also depend on GI absorption. Same spacing principles apply; same recommendation for a TSH recheck 8–12 weeks into GLP-1 treatment.